Rhythm Pharmaceuticals jumps on report AstraZeneca made $10B bid
at seekingalpha.com (Wed, 4-Nov 4:13 PM)
DZ BANK AG Remains a Buy on AstraZeneca (AZN)
at www.tipranks.com (Wed, 4-Nov 2:35 AM)
How health care is on the ballot in the midterms
at seekingalpha.com (Tue, 3-Nov 12:13 PM)
AstraZeneca (AZN) Gets a Buy from Jefferies
at www.tipranks.com (Tue, 3-Nov 8:36 AM)
Goldman Sachs Remains a Buy on AstraZeneca (AZN)
at www.tipranks.com (Tue, 3-Nov 8:35 AM)
Pfizer (PFE) vs. AstraZeneca (AZN): Which Pharma Stock Offers a Better Dividend?
at www.tipranks.com (Tue, 3-Nov 8:05 AM)
Bernstein Remains a Buy on AstraZeneca (AZN)
at www.tipranks.com (Tue, 3-Nov 6:05 AM)
AstraZeneca Reports 1.551 Billion Voting Rights
at www.tipranks.com (Mon, 2-Nov 10:33 AM)
Deutsche Bank Reaffirms Their Hold Rating on AstraZeneca (AZN)
at www.tipranks.com (Mon, 2-Nov 10:30 AM)
RBC Capital Remains a Buy on AstraZeneca (AZN)
at www.tipranks.com (Mon, 2-Nov 3:18 AM)
Citi Sticks to Its Buy Rating for AstraZeneca (AZN)
at www.tipranks.com (Mon, 2-Nov 2:57 AM)
Barclays Sticks to Its Buy Rating for AstraZeneca (AZN)
at www.tipranks.com (Mon, 2-Nov 2:45 AM)
Market Chameleon (Fri, 30-Oct 11:13 AM)
Enhertu’s second Prix Galien honor reinforces AstraZeneca’s ADC momentum
Market Chameleon (Fri, 30-Oct 7:10 AM)
Market Chameleon (Tue, 20-Oct 9:06 AM)
AstraZeneca’s new Kendall Square R&D hub targets nearly 2,000 researchers in Massachusetts
Market Chameleon (Tue, 6-Oct 7:09 AM)
AstraZeneca joins Phase III triple-negative breast cancer trial pairing Datroway with ivonescimab
Market Chameleon (Fri, 2-Oct 9:03 AM)
Market Chameleon (Wed, 26-Aug 7:51 AM)
AstraZeneca’s AI Partnerships Highlight Biotech’s Shift from Code to Function
Market Chameleon (Wed, 19-Aug 9:18 AM)
